SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Civin C, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG1a cells. J Immunol 133: 157165, 1984.
  • 2
    Katz F, Tindle RW, Sutherland DR, Greaves MF: Identification of a membrane glycoprotein associated with hematopoietic progenitor cells. Leuk Res 9: 191198, 1995.
  • 3
    Civin C, Trischman T, Fackler M, Bernstein I, Buhring H, Campos L, Greaves MF, Kamoun M, Katz D, Landsorp P, Look T, Seed B, Sutherland DR, Tindle R, Vchanska-Ziegler B: Summary of CD34 cluster workshop section. In: LeucocyteTypingIV, KnappW, DorkenB, GilksWR, ReiberEP, SchmidtRE, SteinH, von dem BorneAEGKR, eds. Oxford University Press, Oxford, 1989, pp. 818825.
  • 4
    Sutherland DR, Keating A: The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1: 115129, 1992.
  • 5
    Berenson RJ, Andrewes RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein ID: Antigen CD34-positive marrow cells engraft lethally irradiated baboons. J Clin Invest 81: 951955, 1988.
  • 6
    Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamasz DF, Still BJ, Spitzer G, Buckner CD, Bernstein ID, Thomas ED: Engraftment after infusion of CD341 marrow cells in patients with breast cancer or neuroblastoma. Blood 77: 17171722, 1991.
  • 7
    Juttner CA, To LB, Haylock DN, Branford A, Kimber RJ: Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukemia produce prompt but incomplete hematopoietic reconstitution after high-dose melphelan or supralethal chemoradiotherapy. Br J Haematol 61: 739745, 1985.
  • 8
    Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of CD341 hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colonystimulating factor. Blood 74: 19051914, 1989.
  • 9
    To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89: 22332258, 1997.
  • 10
    Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Landsdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400409, 1991.
  • 11
    Trischmann TM, Schepers KG, Civin CI: Measurement of CD341 cells in bone marrow by flow cytometry. J Hematother 2: 305313, 1993.
  • 12
    Kreissig C, Kirsch A, Serke S: Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 3: 263289, 1994.
  • 13
    Bender J, Unverzagt K, Walker D: Hematopoietic stem cells. In: The Mulhouse Manual, WunderE, SovolatH, HenonPR, SerkeS, eds. Alphamed Press, Ohio, 1994, pp. 3143.
  • 14
    Loken MP: Peripheral blood stem cell quantitation. In: OwensMA, LokenMP, eds. Flow Cytometry Principles for Clinical Laboratory Practice. Wiley-Liss, New York, 1995, pp. 111127.
  • 15
    Johnsen HE, Knudsen LM, for the Nordic Stem Cell Laboratory Group (NSCL-G): Nordic flow cytometry standards for CD341 cell enumeration in blood and leukapheresis products: Report from the Second Nordic Workshop. J Hematother 5: 237245, 1996.
  • 16
    Brecher ME, Sims L, Schmitz J, Shea T, Bentley SA: North American multicenter study on flow cytometric enumeration of CD341hematopoietic stem cells. J Hematother 5: 227236, 1996.
  • 17
    Chang A, Ma DDF: The influence of flow cytometric gating strategies on the standardisation of CD341 cell quantitation: An Australian multi-centre study. J Hematother 5: 605616, 1996.
  • 18
    Chin-Yee I, Keeney M, Anderson L, Sutherland DR, for the Canadian QASE Study Group: Quality assurance of stem cell enumeration by flow cytometry. Cytometry 30: 296303, 1997.
  • 19
    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: The ISHAGE guidelines for CD341 cell determination by flow cytometry. J Hematother 5: 213226, 1996.
  • 20
    Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK: Sensitive detection and enumeration of CD341 cells in peripheral and cord blood by flow cytometry. Exp Hematol 22: 10031010, 1994.
  • 21
    Schmid I, Krall WJ, Uittenbogaart C, Braun J, Giorgi JV: Dead cell discrimination with 7-amino actinomycin D in combination with dual color immunofluorescence in single-laser flow cytometry. Cytometry 13: 204208, 1992.
  • 22
    Bland JM, Altman GD: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307310, 1986.
  • 23
    Cobbold S, Hale G, Waldman H: Non-lineage, LFA-1 family and leukocyte common antigens: New and previously defined clusters. In: LeucocyteTypingIII, McMichaelAJ, BeverleyPCL, CobboldS, CrumptonMJ, GilksW, GotchFM, HoggN, HortonM, LingN, MacLennanICM, MasonDY, MilsteinC, SpiegelhalterD, WaldmannH, eds. Oxford University Press, Oxford, 1987, pp. 796803.
  • 24
    Greaves MF, Titley I, Colman SM, Buhring HJ, Campos L, Castoldi GL, Garrido F, Gaudernack G, Girard JP, Ingles-Esteve J, Invernizi R, Knapp W, Lansdorp PM, Lanza F, Merle-Beral H, Parravicini C, Razak K, Ruiz-Cabello F, Springer TA, van der Schoot CE, Sutherland DR: Report on the CD34 cluster workshop. In: LeukocyteTypingV, SchlossmanSF, BoumsellL, GilksW, HarlanJM, KishimotoT, MorimotoC, RitzJ, ShawS, SilversteinR, SpringerT, TedderTF, ToddRF, (eds.) Oxford University Press, Oxford, 1995, pp. 840846.
  • 25
    Roth P, Maples J, Hall J, Dailey T: Use of control cells to standardize enumeration of CD341 stem cells. Ann NY Acad Sci 770: 370372, 1996.
  • 26
    Chin-Yee I, Keeney M, Anderson L, Nayar R, Sutherland DR: Current status of CD341 cell analysis by flow cytometry: The ISHAGE guidelines. Clin Immunol Newslett 17: 2129, 1997.
  • 27
    Johnson ML, Sheesley L, Torke N: CD4 and CD8 absolute counts: A method comparison. Lab Hemat 3: 5359, 1997.
  • 28
    Nicholson JK, Stein D, Mui T, Mack R, Hubbard M, Denny T: Evaluation of a method for counting absolute numbers of cells with a flow cytometer. Clin Diagn Lab Imunol 4: 309313, 1997.
  • 29
    Knape CC: Standardisation of absolute CD34 cell enumeration [letter]. J Hematother 5: 211212, 1996.
  • 30
    Sims LC, Brecher ME, Gertis K, Jenkins A, Nickischer D, Schmitz JL, Sparks S, Wright P, Bentley SA: Enumeration of CD341 stem cells: Evaluation and comparison of three methods. J. Hematother 6: 213226, 1997.
  • 31
    Stewart AK, Imrie K, Keating A, Anania S, Nayar R, Sutherland DR: Optimizing the CD341 Thy-11 stem cell content of peripheral blood collections. Exp Hematol 23: 16191627, 1995.
  • 32
    Sutherland DR, Anderson L, Nayar R, Keeney M, Chin-Yee I: The ISHAGE Guidelines for CD341 cell determination: Applications in autologous and allogeneic blood and marrow transplantation. In: Bone Marrow Transplantation: A Practical Approach, BallE, ListerJ, eds. Churchill Livingstone, 1998, in press.
  • 33
    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: QBEnd10 (CD34) antibody is unsuitable for routine use in the ISHAGE CD341 cell determination assay [response to letter to the editor]. J Hematother 5: 601603, 1996.
  • 34
    Sutherland R, Anderson L, Keeney M, Nayar R, Chin-Yee I: Towards a worldwide standard for CD341 enumeration? [response to letter to the editor] J Hematother 6: 8589, 1997.
  • 35
    Serke S, Huhn D: An all leukocyte whole blood lyse method for multiparameter flow cytometry. J Clin Lab Hematol 15: 275285, 1993.
  • 36
    Bossuyt X, Marti GE, Fleisher TA: Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry 30: 124133, 1997.
  • 37
    Gratma JW, Kraan J, Adriaansen H, Hooibrink B, Levering W, Reinders P, Van den Beemd MW, Van der Holt B, Bolhuis RL. Reduction of interlaboratory variability in flow cytometric imunophenotyping by standardization of instrument set-up and calibration and standard list mode data analysis. Cytometry 30: 1022, 1997.